Peculiarities of COVID-19 coronavirus infection course in patients with comorbid pathology
- Авторлар: Sycheva A.S.1,2, Malyavina M.A.1, Tebueva L.V.1, Grigorievsky E.D.1, Kebina A.L.1,2, Vertkin A.L.1, Solodov A.A.1,2, Semenyakin I.V.1, Levchenko O.V.1, Yanushevich O.O.1
-
Мекемелер:
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
- Clinical medical center of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
- Шығарылым: Том 8, № 6 (2022)
- Беттер: 11-26
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/289136
- DOI: https://doi.org/10.18565/therapy.2022.6.11-26
- ID: 289136
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Alexandra Sycheva
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia; Clinical medical center of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russiaassistant at the Department of therapy, clinical pharmacology and emergency medicine, deputy chief physician for outpatient clinical work of the Clinical Medical Center of the University Hospital
Maria Malyavina
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russiaclinical resident of the Department of therapy, clinical pharmacology and emergency medicine
Lyuaza Tebueva
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia6th year student
Evgeny Grigorievsky
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russianeurosurgeon of the clinic for 184 beds
Anastasia Kebina
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia; Clinical medical center of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russiaassistant at the Department of therapy, clinical pharmacology and emergency medicine, deputy chief physician for medical work of the Clinical Medical Center of the University Hospital
Arkady Vertkin
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
Email: kafedrakf@mail.ru
Dr. med. habil., professor, head of the Department of therapy, clinical pharmacology and emergency medicine
Alexander Solodov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia; Clinical medical center of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
Email: docsol@mail.ru
Dr. med. habil., professor of the Department of neurosurgery and neuroreanimation
Igor Semenyakin
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
Email: dr.semeniakin@gmail.com
Dr. med. habil., associate professor of the Department of urology
Oleg Levchenko
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of RussiaDr. med. habil., professor, vice-rector for medical work
Oleg Yanushevich
A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of RussiaDr. med. habil., professor, academician of RAS, rector
Әдебиет тізімі
- Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229): 1054-62. https://dx.doi.org/10.1016/S0140-6736(20)30566-3.
- Kuster G.M., Pfister O., Burkardet T. et al. SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020; 41(19): 1801-3. https://dx.doi.org/10.1093/eurheartj/ehaa235.
- Ocaranza M.P., Riquelme J.A., Garcia L. et al. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020; 17(2): 116-29. https://dx.doi.org/10.1038/s41569-019-0244-8.
- Guo T., Fan Y., Chen M. et al. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7): 811-18. https://dx.doi.org/10.1001/jamacardio.2020.1017.
- Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 11 (07.05.2021). Минздрав России. Доступ: https://стопкоронавирус.рф/ai/doc/872/attach/Bmr_COVID-19_compressed.pdf (дата обращения - 19.06.2022).
- Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7): 934-43. https://dx.doi.org/10.1001/jamainternmed.2020.0994.
- WHO. 2020. Coronavirus disease 2019 (COVID-19) Situation report - 141. Geneva, Switzerland. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200609-covid-19-sitrep-141.pdf?sfvrsn=72fa1b16_2 (date of access - 19.06.2022).
- Коган Е.А., Березовский Ю.С., Проценко Д.Д. с соавт. Патологическая анатомия инфекции, вызванной SARS-CoV-2. Судебная медицина. 2020; 6(2): 8-30. [Kogan E.A., Berezovsky Yu.S., Protsenko D.D. et al. Pathological anatomy of infection caused by SARS-CoV-2. Sudebnaya meditsina = Russian Journal of Forensic Medicine. 2020; 6(2): 8-30 (In Russ.). https://dx.doi.org/10.19048/2411-8729-2020-6-2-8-30. EDN: WBJMCM.
- Рыбакова М.Г., Карев В.Е., Кузнецова И.А. Патологическая анатомия новой коронавирусной инфекции COVID-19. Первые впечатления. Архив патологии. 2020; 82(5): 5-15. [Rybakova M.G., Karev V.E., Kuznetsova I.A. Anatomical pathology of novel coronavirus (COVID-19) infection. First impressions. Arkhiv patologii = Archive of Pathology. 2020; 82(5): 5-15 (In Russia)]. https://dx.doi.org/10.17116/patol2020820515. EDN: KRELVX.
- CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12 - March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(13): 382-86. https ://dx.doi.org/10.15585/mmwr.mm6913e2.
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-42. https://dx.doi.org/10.1001/jama.2020.2648.
- Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-48. https://dx.doi.org/10.1007/s00134-020-05991-x.
- Hamming I., Timens W., Bulthuis M.L. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203(2): 631-37. https://dx.doi.org/10.1002/path.1570.
- Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-69. https://dx.doi.org/10.1001/jama.2020.1585.
- Libby P., Simon D.I. Inflammation and thrombosis: The clot thickens. Circulation. 2001; 103(13): 1718-20. https://dx.doi.org/10.1161/01.cir.103.13.1718.
- Kwong J.C., Schwartz K.L., Campitelli M.A. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl J. Med. 2018; 378(4): 345-53. https://dx.doi.org/10.1056/NEJMoa1702090.
- Davis M.M., Taubert K., Benin A.L. Influenza vaccination as secondary prevention for cardiovascular disease: A science advisory from the American Heart Association/American College of Cardiology. J. Am Coll Cardiol. 2006; 48(7): 1498-502. https ://dx. doi.org/10.1016/j.jacc.2006.09.004.
- Bonow R.O., Fonarow G.C., O'Gara P.T., Yancy C.W. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020; 5(7): 751-53. https://dx.doi.org/10.1001/jamacardio.2020.1105.
- Chen L., Li X., Chen M. et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116(6): 1097-100. https://dx.doi.org/10.1093/cvr/cvaa078.
- Richardson S., Hirsch J.S., Narasimhan M. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20): 2052-59. https://dx.doi.org/10.1001/jama.2020.6775.
- Zuin M., Rigatelli G., Zuliani G. et al. Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis. J. Infect. 2020; 81(1): e84-e86. https://dx.doi.org/10.1016/j.jinf.2020.03.059.
- Clerkin K.J., Fried J.A., Raikhelkar J. et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020; 141(20): 1648-55. https://dx.doi.org/10.1161/CIRCULATI0NAHA.120.046941.
- Ye Q., Wang B., Mao J. The pathogenesis and treatment of the «Cytokine Storm» in COVID-19. J. Infect. 2020; 80(6): 607-13. https://dx.doi.org/10.1016/j.jinf.2020.03.037.
- Azevedo R.B., Botelho B.G., Hollanda J.V.G. et al. Covid-19 and the cardiovascular system: A comprehensive review. J. Hum Hypertens. 2021; 35(1): 4-11. https://dx.doi.org/10.1038/s41371-020-0387-4.
- Yang G., Tan Z., Zhou L. et al. Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus inhection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: A single-center retrospective study. Hypertension. 2020; 76(1): 51-58. https://dx.doi.org/10.1161/HYPERTENSIONAHA.120.15143.
- ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021; 36(1): 87-94. https://dx.doi.org/10.1093/ndt/gfaa314.
- Верткин А.Л., Носова А.В., Малявина М.А. Как посмотреть больного с ХБП за 15 мин. Электронный вестник «Амбулаторный врач». Выпуск №56. Доступ: https://ambdoc.ru/learning/electronic-bulletin/ambulatornyy-blits-56/(дата обращения - 19.06.2022).
- Забозлаев Ф.Г., Кравченко Э.В., Галлямова А.Р., Летуновский Н.Н. Патологическая анатомия легких при новой коронавирусной инфекции (COVID-19). Предварительный анализ аутопсийных исследований. Клиническая практика. 2020; 11(2): 21-37. https://dx.doi.org/10.17816/clinpract34849. EDN: VQZRAV.
- Самсонова М.В., Черняев А.Л., Михалева Л.М. с соавт. Патологическая анатомия легких при COVID-19. атлас. М. - Рязань: Рязанская областная типография. 2020; 51 с. [Camsonova M.V., Chernyaev A.L., Mikhaleva L.M. et al. Pathological anatomy of the lungs in COVID-19. Atlas. Moscow - Ryazan: Ryazan Regional Printing House. 2020; 51 pp. (In Russ.)]. ISBN: 978-5-91255-313-4.
- Astuti I., Ysrafil. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr. 2020; 14(4): 407-12. https://dx.doi.org/10.1016/j.dsx.2020.04.020.
- Elezkurtaj S., Greuel S., Ihlow J. et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 2021; 11(1): 4263. https://dx.doi.org/10.1038/s41598-021-82862-5.
- Zafer M. M., El-Mahallawy H.A., Ashour H.M. Severe COVID-19 and sepsis: Immune pathogenesis and laboratory markers. Microorganisms. 2021; 9(1): 159. https://dx.doi.org/10.3390/microorganisms9010159.
- Заиратьянц О.В., Cамсонова М.В., Михалева Л.М. с соавт. Патологическая анатомия COVID-19: атлас. Под общей ред. О.В. Зайратьянца. М.: ГБУ «НИИОЗММ ДЗМ». 2020; 140 с. [Zairatyants O.V., Kamsonova M.V., Mikhaleva L.M. et al. The pathological anatomy of COVID-19. Atlas. Ed. by O.V. Zayratyan. Moscow: Research Institute of Health Organization and Medical Management of the Moscow Healthcare Department. 2020; 140 pp. (In Russ.)]. ISBN: 978-5-907251-57-1.
- Зайратьянц О.В., Самсонова М.В., Черняев А.Л. с соавт. Патологическая анатомия COVID-19: опыт 2000 аутопсий. Судебная медицина. 2020; 6(4): 10-23. [Zayratyants O.V., Samsonova M.V., Chernyaev A.L. et al. COVID-19 pathology: experience of 2000 autopsies. Sudebnaya meditsina = Russian Journal of Forensic Medicine. 2020; 6(4): 10-23 (In Russ.)]. https://dx.doi.org/10.19048/fm340. EDN: BJQIYY.
- Centers for Disease Control and Prevention (CDC). Coronavirus disease 2019 (COVID-19): Evaluating and testing persons for coronavirus disease 2019 (COVID- 19). URL: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html (date of access - 19.06.2022).